Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
Elkins David VEVP, Chief Financial Officer
|
Tax withholdingCommon Stock, $0.10 par value | 5,087 | $62.18 | $316,309.66 |
DisclosureSEC source: 0000014272-20-000297 · wf-form4_160704502687137.xml · nonDerivative · entry 2 Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,487 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
Elkins David VEVP, Chief Financial Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 8,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000297 · wf-form4_160704502687137.xml · nonDerivative · entry 1 Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
AHMED NADIMEVP and President, Hematology
|
Exercise / conversionRestricted Stock Units · Derivative | 6,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000298 · wf-form4_160704504862220.xml · derivative · entry 4 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,782 Underlying: Common Stock, $0.10 par value · 6,594 shares Expires 2023-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
AHMED NADIMEVP and President, Hematology
|
Tax withholdingCommon Stock, $0.10 par value | 3,380 | $62.18 | $210,168.40 |
DisclosureSEC source: 0000014272-20-000298 · wf-form4_160704504862220.xml · nonDerivative · entry 2 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,603 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
AHMED NADIMEVP and President, Hematology
|
Exercise / conversionCommon Stock, $0.10 par value | 6,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000298 · wf-form4_160704504862220.xml · nonDerivative · entry 1 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionRestricted Stock Units · Derivative | 8,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000299 · wf-form4_160704506656734.xml · derivative · entry 4 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,376 Underlying: Common Stock, $0.10 par value · 8,792 shares Expires 2023-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 4,506 | $62.18 | $280,183.08 |
DisclosureSEC source: 0000014272-20-000299 · wf-form4_160704506656734.xml · nonDerivative · entry 2 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,208 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 01:24 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 8,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000299 · wf-form4_160704506656734.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000291 · wf-form4_160703370404217.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock, $0.10 par value · 2,825 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
Tax withholdingCommon Stock, $0.10 par value | 968 | $62.41 | $60,412.88 |
DisclosureSEC source: 0000014272-20-000291 · wf-form4_160703370404217.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,391 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
Exercise / conversionCommon Stock, $0.10 par value | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000291 · wf-form4_160703370404217.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 22:52 UTC |
von Autenried PaulEVP, Chief Information Officer
|
SaleCommon Stock, $0.10 par value | 3 | $63.50 | $190.50 |
DisclosureSEC source: 0000014272-20-000289 · wf-form4_160677674721292.xml · nonDerivative · entry 1 von Autenried Paul · CIK 0001524143 · EVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,698.066 F1 · shares: Shares were sold pursuant to a limit order. Read SEC document |
| November 25, 2020 Filed Feb 9, 2021 00:29 UTC |
Caforio GiovanniDirector · Chairman and CEO
|
GiftCommon Stock, $0.10 par value | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000063 · wf-form5_161283053601206.xml · nonDerivative · entry 1 Caforio Giovanni · CIK 0001533201 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,104.333 F1 · shares: This transaction involved a donation of securities by the Reporting Person to a charitable organization. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:31 UTC |
von Autenried PaulEVP, Chief Information Officer
|
SaleCommon Stock, $0.10 par value | 20,000 | $62.75 | $1,255,000.00 |
DisclosureSEC source: 0000014272-20-000285 · wf-form4_160633989604016.xml · nonDerivative · entry 1 von Autenried Paul · CIK 0001524143 · EVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,701.066 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.50 to $63.00, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.50 to $63.00, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:32 UTC |
Dubow AdamSVP,ChiefCompliance&EthicsOff.
|
SaleCommon Stock, $0.10 par value | 900 | $63.39 | $57,051.00 |
DisclosureSEC source: 0000014272-20-000286 · wf-form4_160633992053726.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,186.152 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $63.385 to $63.386, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $63.385 to $63.386, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:32 UTC |
Vessey RupertEVP, Research & Early Dev.
|
SaleCommon Stock, $0.10 par value | 13,421 | $61.34 | $823,244.14 |
DisclosureSEC source: 0000014272-20-000287 · wf-form4_160633994006501.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,922 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.33 to $61.35, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.33 to $61.35, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 8,487 | $0.00 Strike: $38.41 | $0.00 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · derivative · entry 13 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,981 Underlying: Common Stock, $0.10 par value · 8,487 shares Expires 2028-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 8,489 | $0.00 Strike: $47.81 | $0.00 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · derivative · entry 12 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,980 Underlying: Common Stock, $0.10 par value · 8,489 shares Expires 2028-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 8,489 | $0.00 Strike: $44.70 | $0.00 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · derivative · entry 11 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,980 Underlying: Common Stock, $0.10 par value · 8,489 shares Expires 2028-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 12,233 | $0.00 Strike: $54.29 | $0.00 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · derivative · entry 10 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,233 Underlying: Common Stock, $0.10 par value · 12,233 shares Expires 2027-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 14,515 | $0.00 Strike: $54.94 | $0.00 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · derivative · entry 9 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 14,515 shares Expires 2026-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
SaleCommon Stock, $0.10 par value | 47,012 | $61.31 | $2,882,305.72 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 7 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,343 F2 · shares: 47,012 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.21 to $61.36, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · price: 47,012 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.21 to $61.36, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 8,487 | $38.41 | $325,985.67 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 6 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 8,489 | $47.81 | $405,859.09 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 5 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 8,489 | $44.70 | $379,458.30 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 4 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 12,233 | $54.29 | $664,129.57 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 3 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 14,515 | $54.94 | $797,454.10 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 2 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:40 UTC |
Vessey RupertEVP, Research & Early Dev.
|
SaleCommon Stock, $0.10 par value | 10,579 | $61.25 | $647,963.75 |
DisclosureSEC source: 0000014272-20-000281 · wf-form4_160617121293210.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,142 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.19 to $61.29, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.19 to $61.29, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:27 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionRestricted Stock Units · Derivative | 5,804 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000274 · wf-form4_160443883877358.xml · derivative · entry 4 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,804 shares Expires 2020-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on October 30, 2018. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:27 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 2,859 | $58.45 | $167,108.55 |
DisclosureSEC source: 0000014272-20-000274 · wf-form4_160443883877358.xml · nonDerivative · entry 2 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,721 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:27 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 5,804 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000274 · wf-form4_160443883877358.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in three equal annual installments beginning on October 30, 2018. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:28 UTC |
AHMED NADIMEVP and President, Hematology
|
Exercise / conversionRestricted Stock Units · Derivative | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000275 · wf-form4_160443891475377.xml · derivative · entry 4 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,650 shares Expires 2020-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on October 30, 2018. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:28 UTC |
AHMED NADIMEVP and President, Hematology
|
Tax withholdingCommon Stock, $0.10 par value | 2,291 | $58.45 | $133,908.95 |
DisclosureSEC source: 0000014272-20-000275 · wf-form4_160443891475377.xml · nonDerivative · entry 2 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,389 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:28 UTC |
AHMED NADIMEVP and President, Hematology
|
Exercise / conversionCommon Stock, $0.10 par value | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000275 · wf-form4_160443891475377.xml · nonDerivative · entry 1 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in three equal annual installments beginning on October 30, 2018. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:29 UTC |
Rice Derica WDirector
|
GrantDeferred Share Units · Derivative | 149.414 | $60.29 | $9,008.17 |
DisclosureSEC source: 0000014272-20-000260 · wf-form4_160167054678485.xml · derivative · entry 1 Rice Derica W · CIK 0001359067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,455.693 Underlying: Common Stock, $0.10 par value · 149.414 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:29 UTC |
BONNEY MICHAEL WDirector
|
GrantDeferred Share Units · Derivative | 382.733 | $60.29 | $23,074.97 |
DisclosureSEC source: 0000014272-20-000261 · wf-form4_160167056399310.xml · derivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,057.255 Underlying: Common Stock, $0.10 par value · 382.733 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:29 UTC |
Storch Gerald LDirector
|
GrantDeferred Share Units · Derivative | 580.527 | $60.29 | $34,999.97 |
DisclosureSEC source: 0000014272-20-000262 · wf-form4_160167058228309.xml · derivative · entry 1 Storch Gerald L · CIK 0001205004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,625.212 Underlying: Common Stock, $0.10 par value · 580.527 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:30 UTC |
Samuels Theodore R. IIDirector
|
GrantDeferred Share Units · Derivative | 539.061 | $60.29 | $32,499.99 |
DisclosureSEC source: 0000014272-20-000263 · wf-form4_160167060117345.xml · derivative · entry 1 Samuels Theodore R. II · CIK 0001688276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,741.081 Underlying: Common Stock, $0.10 par value · 539.061 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:30 UTC |
Haller Julia ADirector
|
GrantDeferred Share Units · Derivative | 539.061 | $60.29 | $32,499.99 |
DisclosureSEC source: 0000014272-20-000264 · wf-form4_160167062234972.xml · derivative · entry 1 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,507.151 Underlying: Common Stock, $0.10 par value · 539.061 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:30 UTC |
Arduini Peter JDirector
|
GrantDeferred Share Units · Derivative | 601.261 | $60.29 | $36,250.03 |
DisclosureSEC source: 0000014272-20-000265 · wf-form4_160167064183367.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,468.481 Underlying: Common Stock, $0.10 par value · 601.261 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:31 UTC |
BERTOLINI ROBERT JDirector
|
GrantDeferred Share Units · Derivative | 580.527 | $60.29 | $34,999.97 |
DisclosureSEC source: 0000014272-20-000266 · wf-form4_160167065837612.xml · derivative · entry 1 BERTOLINI ROBERT J · CIK 0001270263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,128.215 Underlying: Common Stock, $0.10 par value · 580.527 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:31 UTC |
Emmens MatthewDirector
|
GrantDeferred Share Units · Derivative | 601.261 | $60.29 | $36,250.03 |
DisclosureSEC source: 0000014272-20-000267 · wf-form4_160167068073141.xml · derivative · entry 1 Emmens Matthew · CIK 0001298332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,433.803 Underlying: Common Stock, $0.10 par value · 601.261 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:32 UTC |
Price Paula ADirector
|
GrantDeferred Share Units · Derivative | 37.353 | $60.29 | $2,252.01 |
DisclosureSEC source: 0000014272-20-000268 · wf-form4_160167070003245.xml · derivative · entry 1 Price Paula A · CIK 0001369240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,343.632 Underlying: Common Stock, $0.10 par value · 37.353 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:32 UTC |
YALE PHYLLIS RDirector
|
GrantDeferred Share Units · Derivative | 476.862 | $60.29 | $28,750.01 |
DisclosureSEC source: 0000014272-20-000269 · wf-form4_160167073815300.xml · derivative · entry 1 YALE PHYLLIS R · CIK 0001269070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404.701 Underlying: Common Stock, $0.10 par value · 476.862 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:32 UTC |
Paliwal Dinesh CDirector
|
GrantDeferred Share Units · Derivative | 642.727 | $60.29 | $38,750.01 |
DisclosureSEC source: 0000014272-20-000270 · wf-form4_160167075500939.xml · derivative · entry 1 Paliwal Dinesh C · CIK 0001360224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,650.905 Underlying: Common Stock, $0.10 par value · 642.727 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:33 UTC |
Vousden Karen HDirector
|
GrantDeferred Share Units · Derivative | 160.682 | $60.29 | $9,687.52 |
DisclosureSEC source: 0000014272-20-000271 · wf-form4_160167077440287.xml · derivative · entry 1 Vousden Karen H · CIK 0001723884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,345.169 Underlying: Common Stock, $0.10 par value · 160.682 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 21:29 UTC |
Rice Derica WDirector
|
SaleCall Option (obligation to sell) · Derivative | 12 | $72.50 Strike: $72.50 | $870.00 |
DisclosureSEC source: 0000014272-20-000245 · wf-form4_159960053331850.xml · derivative · entry 1 Rice Derica W · CIK 0001359067 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 1,200 shares Expires 2021-01-15 Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:33 UTC |
Rice Derica WDirector
|
GrantDeferred Share Units · Derivative | 1,306.279 | $60.97 | $79,643.83 |
DisclosureSEC source: 0000014272-20-000239 · wf-form4_159907878786596.xml · derivative · entry 1 Rice Derica W · CIK 0001359067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306.279 Underlying: Common Stock, $0.10 par value · 1,306.279 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · shares: Represents pro rata portion of the 2020 annual Deferred Share Unit awards granted to the Company's directors. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:33 UTC |
Santiago Karen MurphySVP & Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 642 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000238 · wf-form4_159907876937346.xml · derivative · entry 3 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 642 shares Expires 2020-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: Represents vesting of one-quarter of restricted stock units granted on September 1, 2016. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted stock units granted on September 1, 2016. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted stock units granted on September 1, 2016. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:33 UTC |
Santiago Karen MurphySVP & Controller
|
Tax withholdingCommon Stock, $0.10 par value | 220 | $60.97 | $13,413.40 |
DisclosureSEC source: 0000014272-20-000238 · wf-form4_159907876937346.xml · nonDerivative · entry 2 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,170 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.